Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (211-220 of 542) with videos related to

Pageof 55
Sort By:
Diagnostic Microbiology and Infectious Disease|October 1, 1996
Transmission of Citrobacter koseri from mother to infant documented by ribotyping and pulsed-field gel electrophoresisC J Papasian, J Kinney, S Coffman, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2008
In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis modelD R Andes, D J Diekema, M A Pfaller, et al.
Journal of Clinical Microbiology|October 1, 1988
Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolatesM A Pfaller, T Preston, M Bale, et al.
Journal of Global Antimicrobial Resistance|July 24, 2017
Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013-2015)M A Pfaller, D Shortridge, H S Sader, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 6, 2010
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methodsM A Pfaller, D Andes, D J Diekema, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1988
Comparison of the lysis centrifugation and radiometric blood culture systems for recovery of yeastB A Body, M A Pfaller, J Durrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 1998
Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance programG V Doern, M A Pfaller, K Kugler, et al.
Journal of Clinical Microbiology|November 29, 2001
Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida speciesM A Pfaller, S A Messer, K Mills, et al.
Journal of Clinical Microbiology|September 28, 2001
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococciT Yamazumi, I Furuta, D J Diekema, et al.
International Journal of Antimicrobial Agents|October 11, 2017
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015)M A Pfaller, D Shortridge, H S Sader, et al.
Pageof 55

Showing results (211-220 of 542) with videos related to

Sort By:
Pageof 55
Diagnostic Microbiology and Infectious Disease|October 1, 1996
Transmission of Citrobacter koseri from mother to infant documented by ribotyping and pulsed-field gel electrophoresisC J Papasian, J Kinney, S Coffman, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2008
In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis modelD R Andes, D J Diekema, M A Pfaller, et al.
Journal of Clinical Microbiology|October 1, 1988
Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolatesM A Pfaller, T Preston, M Bale, et al.
Journal of Global Antimicrobial Resistance|July 24, 2017
Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013-2015)M A Pfaller, D Shortridge, H S Sader, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 6, 2010
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methodsM A Pfaller, D Andes, D J Diekema, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1988
Comparison of the lysis centrifugation and radiometric blood culture systems for recovery of yeastB A Body, M A Pfaller, J Durrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 1998
Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance programG V Doern, M A Pfaller, K Kugler, et al.
Journal of Clinical Microbiology|November 29, 2001
Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida speciesM A Pfaller, S A Messer, K Mills, et al.
Journal of Clinical Microbiology|September 28, 2001
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococciT Yamazumi, I Furuta, D J Diekema, et al.
International Journal of Antimicrobial Agents|October 11, 2017
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015)M A Pfaller, D Shortridge, H S Sader, et al.
Pageof 55